Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Haemonetics (NYSE: HAE) will publish fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics (NYSE: HAE) will publish fourth quarter and fiscal year 2026 results at 6:00 am ET on May 7, 2026. A conference call with investors and analysts is scheduled for 8:00 am ET on May 7, 2026.
Participants can join via teleconference after registration to receive a dial-in number and personalized PIN. A live webcast will be available on Haemonetics' investor relations website and a replay will be accessible for one year starting May 7, 2026 at 11:00 am ET.
Details
News Market Reaction – HAE
On Apr 2, the first trading day after this news, HAE closed 1.05% above the previous close.
Data tracked by StockTitan Argus for the Apr 2 session.
Key Figures
- Earnings release time
- 6:00 am ET
- Fourth quarter and fiscal year 2026 results on May 7, 2026
- Conference call time
- 8:00 am ET
- Investor and analyst call on May 7, 2026
- Earnings date
- May 7, 2026
- Scheduled publication of Q4 and FY26 results
- Replay duration
- 1 year
- Conference call and webcast replay availability starting May 7, 2026
Previous Earnings date Reports
-
Announced Q3 FY26 results release timing and related conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call can be accessed via teleconference at: Q4 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/7d678otf
A replay of the conference call and webcast will be available for one year beginning on May 7, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of
hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | ||
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations | |
(781) 356-9763 | (203) 733-4987 | |
Media Contact: | ||
Josh Gitelson, Sr. Director-Global Communications | ||
(781) 356-9776 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2026-results-may-7-2026-302731954.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.